BMY trims earnings outlook despite revenue beat and upbeat drug sales, sending shares to a 52-week low before a rebound. We ...

Further evidence that US Department of Health and Human Services (HHS) secretary Robert F Kennedy Junior (RFK Jr) is willing ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Pfizer beats Q2 2025 estimates, raises EPS guidance, boasts a 7%+ dividend yield, yet faces patent and pricing risks. See why ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Global vaccine stocks traded lower on Wednesday after the U.S. Department of Health and Human Services announced it would ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Pfizer stock jumped Tuesday after the S&P 500 pharma titan beat second-quarter expectations on the back of solid cost-cutting ...

BioNTech also laid off 63 employees in June in conjunction with the discontinuation of its cell therapy manufacturing ...

Victoria is cementing its position as a global hub for biotechnology and life sciences, with BioNTech establishing a state-of ...